宏潤建設(002062.SZ)中標9.28億元蘇州市軌道交通工程土建施工項目VII-TS06標項目
格隆匯 8 月 4日丨宏潤建設(002062.SZ)公佈,公司於近日收到蘇州市公共資源交易中標通知書,蘇州市軌道交通7號線(第二批)、8號線(第四批)工程土建施工項目VII-TS06標項目由公司中標承建,工程中標價約9.28億元。
項目範圍及內容:地下車站:通園路站、婁葑站、東興路西站;盾構區間:中新大道西站~通園路站區間、通園路站~婁葑站區間、婁葑鎮站~東興路西站、東興路西~羣星二路。
該工程的中標有利於進一步提升公司軌道交通業務市場競爭力和市場份額。該工程中標價佔公司2019年度營業收入的7.77%,對公司2020年度及未來財務狀況和經營成果無重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.